(-)-demecolcine increases expression ISO RGD:1345403 6480464 Demecolcine results in increased expression of BCAT1 mRNA CTD PMID:23649840 17alpha-ethynylestradiol affects expression ISO RGD:735669 6480464 Ethinyl Estradiol affects the expression of BCAT1 mRNA CTD PMID:17555576 17alpha-ethynylestradiol increases expression ISO RGD:735669 6480464 Ethinyl Estradiol results in increased expression of BCAT1 mRNA CTD PMID:16467188 , PMID:17942748 17alpha-ethynylestradiol multiple interactions ISO RGD:735669 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of BCAT1 mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of BCAT1 mRNA CTD PMID:15834898 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of BCAT1 mRNA CTD PMID:17351261 17beta-estradiol increases expression ISO RGD:735669 6480464 Estradiol results in increased expression of BCAT1 mRNA CTD PMID:15289156 17beta-estradiol multiple interactions ISO RGD:1345403 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of BCAT1 mRNA, [Estradiol co-treated with Progesterone] results in increased expression of BCAT1 mRNA CTD PMID:20660070 , PMID:20823114 17beta-estradiol increases expression ISO RGD:1345403 6480464 Estradiol results in increased expression of BCAT1 mRNA CTD PMID:23019147 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:735669 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of BCAT1 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of BCAT1 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of BCAT1 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1345403 6480464 Tetrachlorodibenzodioxin results in decreased expression of BCAT1 mRNA CTD PMID:20106945 , PMID:21632981 2,3-dimethoxynaphthalene-1,4-dione decreases expression ISO RGD:1345403 6480464 2 more ... CTD PMID:17547211 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:23196670 4-hydroxyphenyl retinamide increases expression ISO RGD:735669 6480464 Fenretinide results in increased expression of BCAT1 mRNA CTD PMID:28973697 4-hydroxyphenyl retinamide decreases expression ISO RGD:735669 6480464 Fenretinide results in decreased expression of BCAT1 mRNA CTD PMID:28973697 5-azacytidine decreases expression ISO RGD:1345403 6480464 Azacitidine results in decreased expression of BCAT1 mRNA CTD PMID:20823114 5-fluorouracil multiple interactions ISO RGD:1345403 6480464 TP53 protein affects the reaction [Fluorouracil results in decreased expression of BCAT1 mRNA] CTD PMID:15016801 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of BCAT1 mRNA CTD PMID:24780913 8-Br-cAMP increases expression ISO RGD:1345403 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of BCAT1 mRNA CTD PMID:22079614 acetamide increases expression EXP 6480464 acetamide results in increased expression of BCAT1 mRNA CTD PMID:31881176 aflatoxin B1 affects expression ISO RGD:1345403 6480464 Aflatoxin B1 affects the expression of BCAT1 protein CTD PMID:20106945 aflatoxin B1 decreases methylation ISO RGD:1345403 6480464 Aflatoxin B1 results in decreased methylation of BCAT1 intron CTD PMID:30157460 aflatoxin B1 increases methylation ISO RGD:1345403 6480464 Aflatoxin B1 results in increased methylation of BCAT1 gene CTD PMID:27153756 aflatoxin B1 decreases expression ISO RGD:1345403 6480464 Aflatoxin B1 results in decreased expression of BCAT1 mRNA CTD PMID:21632981 , PMID:21641981 Aflatoxin B2 alpha increases methylation ISO RGD:1345403 6480464 aflatoxin B2 results in increased methylation of BCAT1 5' UTR, aflatoxin B2 results in increased methylation of BCAT1 intron CTD PMID:30157460 aflatoxin M1 decreases expression ISO RGD:1345403 6480464 Aflatoxin M1 results in decreased expression of BCAT1 mRNA CTD PMID:30928695 all-trans-retinoic acid decreases expression ISO RGD:1345403 6480464 Tretinoin results in decreased expression of BCAT1 mRNA CTD PMID:15498508 more ... allyl alcohol increases expression EXP 6480464 allyl alcohol results in increased expression of BCAT1 mRNA CTD PMID:23558518 Allylamine increases expression EXP 6480464 Allylamine results in increased expression of BCAT1 mRNA CTD PMID:23558518 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of BCAT1 mRNA CTD PMID:16483693 aristolochic acid A decreases expression ISO RGD:1345403 6480464 aristolochic acid I results in decreased expression of BCAT1 mRNA CTD PMID:33212167 arsenite(3-) decreases methylation ISO RGD:1345403 6480464 arsenite results in decreased methylation of BCAT1 promoter CTD PMID:23974009 atrazine decreases expression ISO RGD:1345403 6480464 Atrazine results in decreased expression of BCAT1 mRNA CTD PMID:22378314 benzo[a]pyrene decreases expression ISO RGD:735669 6480464 Benzo(a)pyrene results in decreased expression of BCAT1 mRNA CTD PMID:22228805 benzo[a]pyrene affects methylation ISO RGD:1345403 6480464 Benzo(a)pyrene affects the methylation of BCAT1 intron, Benzo(a)pyrene affects the methylation of BCAT1 promoter CTD PMID:27901495 , PMID:30157460 benzo[a]pyrene increases methylation ISO RGD:1345403 6480464 Benzo(a)pyrene results in increased methylation of BCAT1 exon CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:1345403 6480464 Benzo(a)pyrene results in decreased expression of BCAT1 mRNA, Benzo(a)pyrene results in decreased expression of BCAT1 protein CTD PMID:20064835 more ... benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1345403 6480464 7 more ... CTD PMID:26238291 benzo[e]pyrene increases methylation ISO RGD:1345403 6480464 benzo(e)pyrene results in increased methylation of BCAT1 intron CTD PMID:30157460 beta-naphthoflavone decreases expression ISO RGD:1345403 6480464 beta-Naphthoflavone results in decreased expression of BCAT1 mRNA CTD PMID:32858204 bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of BCAT1 mRNA CTD PMID:31199487 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Testosterone] results in increased expression of BCAT1 mRNA, [bisphenol A co-treated with tributyltin] results in decreased expression of BCAT1 mRNA CTD PMID:26496021 , PMID:31129395 bisphenol A affects expression ISO RGD:735669 6480464 bisphenol A affects the expression of BCAT1 mRNA CTD PMID:35341816 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of BCAT1 mRNA CTD PMID:34947998 bisphenol A multiple interactions ISO RGD:1345403 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of BCAT1 gene CTD PMID:31601247 bisphenol A decreases methylation ISO RGD:1345403 6480464 bisphenol A results in decreased methylation of BCAT1 gene CTD PMID:31601247 bisphenol A increases expression ISO RGD:1345403 6480464 bisphenol A analog results in increased expression of BCAT1 mRNA CTD PMID:32387340 Bisphenol B increases expression ISO RGD:1345403 6480464 bisphenol B results in increased expression of BCAT1 protein CTD PMID:34186270 bisphenol F increases expression ISO RGD:1345403 6480464 bisphenol F results in increased expression of BCAT1 protein CTD PMID:34186270 bucladesine multiple interactions ISO RGD:1345403 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of BCAT1 mRNA CTD PMID:20823114 Butylbenzyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of BCAT1 mRNA CTD PMID:31199487 cadmium atom affects expression ISO RGD:1345403 6480464 Cadmium affects the expression of BCAT1 mRNA CTD PMID:21120746 cadmium dichloride increases expression ISO RGD:1345403 6480464 Cadmium Chloride results in increased expression of BCAT1 mRNA, Cadmium Chloride results in increased expression of BCAT1 protein CTD PMID:24527689 , PMID:25596134 calcidiol decreases expression EXP 6480464 Calcifediol deficiency results in decreased expression of BCAT1 mRNA CTD PMID:17293106 carbamazepine affects expression ISO RGD:1345403 6480464 Carbamazepine affects the expression of BCAT1 mRNA CTD PMID:25979313 carbofuran increases expression EXP 6480464 Carbofuran results in increased expression of BCAT1 mRNA CTD PMID:20211217 carbon nanotube increases expression ISO RGD:735669 6480464 Nanotubes more ... CTD PMID:25554681 chlordecone increases expression ISO RGD:735669 6480464 Chlordecone results in increased expression of BCAT1 mRNA CTD PMID:33711761 chloroacetaldehyde affects expression ISO RGD:1345403 6480464 chloroacetaldehyde affects the expression of BCAT1 mRNA CTD PMID:25596134 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of BCAT1 mRNA CTD PMID:22023808 cisplatin decreases expression ISO RGD:1345403 6480464 Cisplatin results in decreased expression of BCAT1 mRNA CTD PMID:25596134 more ... clodronic acid increases expression ISO RGD:1345403 6480464 Clodronic Acid results in increased expression of BCAT1 mRNA CTD PMID:25596134 cobalt dichloride decreases expression ISO RGD:1345403 6480464 cobaltous chloride results in decreased expression of BCAT1 mRNA CTD PMID:19320972 cocaine affects expression EXP 6480464 Cocaine affects the expression of BCAT1 mRNA CTD PMID:20187946 copper atom increases expression EXP 6480464 Copper results in increased expression of BCAT1 mRNA CTD PMID:22465980 copper atom decreases expression EXP 6480464 Copper results in decreased expression of BCAT1 mRNA CTD PMID:30556269 copper(0) increases expression EXP 6480464 Copper results in increased expression of BCAT1 mRNA CTD PMID:22465980 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of BCAT1 mRNA CTD PMID:30556269 copper(II) sulfate increases expression ISO RGD:1345403 6480464 Copper Sulfate results in increased expression of BCAT1 mRNA CTD PMID:19549813 cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of BCAT1 mRNA CTD PMID:23558518 cyclosporin A increases expression ISO RGD:1345403 6480464 Cyclosporine results in increased expression of BCAT1 mRNA CTD PMID:20106945 more ... DDT decreases expression EXP 6480464 DDT results in decreased expression of BCAT1 mRNA CTD PMID:30207508 deguelin increases expression ISO RGD:1345403 6480464 deguelin results in increased expression of BCAT1 mRNA CTD PMID:33512557 dexamethasone decreases expression ISO RGD:735669 6480464 Dexamethasone results in decreased expression of BCAT1 mRNA CTD PMID:22733784 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of BCAT1 mRNA CTD PMID:21266533 dibutyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of BCAT1 mRNA CTD PMID:31199487 dieldrin increases expression EXP 6480464 Dieldrin results in increased expression of BCAT1 mRNA CTD PMID:23153324 diethyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of BCAT1 mRNA CTD PMID:31199487 diethylstilbestrol increases expression ISO RGD:735669 6480464 Diethylstilbestrol results in increased expression of BCAT1 mRNA CTD PMID:15171707 , PMID:15289156 diisobutyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of BCAT1 mRNA CTD PMID:31199487 diisononyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of BCAT1 mRNA CTD PMID:31199487 dioxygen affects expression ISO RGD:1345403 6480464 Oxygen deficiency affects the expression of BCAT1 mRNA CTD PMID:25596134 dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of BCAT1 mRNA CTD PMID:33729688 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of BCAT1 mRNA CTD PMID:20211217 , PMID:23558518 doxorubicin decreases expression ISO RGD:1345403 6480464 Doxorubicin results in decreased expression of BCAT1 mRNA CTD PMID:29803840 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of BCAT1 mRNA CTD PMID:29391264 enzyme inhibitor multiple interactions ISO RGD:1345403 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of BCAT1 protein CTD PMID:23301498 ethanol affects splicing ISO RGD:735669 6480464 Ethanol affects the splicing of BCAT1 mRNA CTD PMID:30319688 ethyl methanesulfonate decreases expression ISO RGD:1345403 6480464 Ethyl Methanesulfonate results in decreased expression of BCAT1 mRNA CTD PMID:23649840 fenofibrate decreases expression ISO RGD:1345403 6480464 Fenofibrate results in decreased expression of BCAT1 mRNA CTD PMID:25596134 folic acid decreases expression ISO RGD:735669 6480464 Folic Acid results in decreased expression of BCAT1 mRNA CTD PMID:25629700 formaldehyde increases expression ISO RGD:1345403 6480464 Formaldehyde results in increased expression of BCAT1 mRNA CTD PMID:23649840 , PMID:27664576 fulvestrant multiple interactions ISO RGD:1345403 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of BCAT1 gene CTD PMID:31601247 furan increases expression EXP 6480464 furan results in increased expression of BCAT1 mRNA CTD PMID:27387713 genistein increases expression ISO RGD:735669 6480464 Genistein results in increased expression of BCAT1 mRNA CTD PMID:15289156 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of BCAT1 mRNA CTD PMID:33387578 heptachlor increases expression EXP 6480464 Heptachlor results in increased expression of BCAT1 mRNA CTD PMID:23153324 hydrogen peroxide decreases expression ISO RGD:1345403 6480464 Hydrogen Peroxide results in decreased expression of BCAT1 mRNA CTD PMID:34581912 ifosfamide decreases expression ISO RGD:1345403 6480464 Ifosfamide results in decreased expression of BCAT1 mRNA CTD PMID:25596134 isoprenaline increases expression EXP 6480464 Isoproterenol results in increased expression of BCAT1 mRNA CTD PMID:20211217 more ... lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of BCAT1 mRNA CTD PMID:11578147 lead diacetate increases expression ISO RGD:735669 6480464 lead acetate results in increased expression of BCAT1 mRNA CTD PMID:25270620 medroxyprogesterone acetate multiple interactions ISO RGD:1345403 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of BCAT1 mRNA CTD PMID:20823114 metacetamol decreases expression ISO RGD:735669 6480464 3-hydroxyacetanilide results in decreased expression of BCAT1 mRNA CTD PMID:18544908 metaproterenol increases expression EXP 6480464 Metaproterenol results in increased expression of BCAT1 mRNA CTD PMID:23558518 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of BCAT1 mRNA CTD PMID:23558518 methapyrilene increases methylation ISO RGD:1345403 6480464 Methapyrilene results in increased methylation of BCAT1 intron CTD PMID:30157460 methyl methanesulfonate decreases expression ISO RGD:1345403 6480464 Methyl Methanesulfonate results in decreased expression of BCAT1 mRNA CTD PMID:23649840 mirex increases expression EXP 6480464 Mirex results in increased expression of BCAT1 mRNA CTD PMID:23153324 mitoxantrone increases expression EXP 6480464 Mitoxantrone results in increased expression of BCAT1 mRNA CTD PMID:23558518 N-methyl-4-phenylpyridinium increases expression ISO RGD:1345403 6480464 1-Methyl-4-phenylpyridinium results in increased expression of BCAT1 mRNA CTD PMID:24810058 neomycin decreases expression ISO RGD:735669 6480464 Neomycin results in decreased expression of BCAT1 mRNA CTD PMID:30626089 nickel atom increases expression ISO RGD:1345403 6480464 Nickel results in increased expression of BCAT1 mRNA CTD PMID:25583101 orciprenaline increases expression EXP 6480464 Metaproterenol results in increased expression of BCAT1 mRNA CTD PMID:23558518 paracetamol decreases expression ISO RGD:735669 6480464 Acetaminophen results in decreased expression of BCAT1 mRNA CTD PMID:18544908 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of BCAT1 mRNA CTD PMID:33387578 paracetamol decreases expression ISO RGD:1345403 6480464 Acetaminophen results in decreased expression of BCAT1 mRNA CTD PMID:21420995 paraquat increases expression EXP 6480464 Paraquat results in increased expression of BCAT1 mRNA CTD PMID:32680482 pentane-2,3-dione increases expression EXP 6480464 2, 3-pentanedione results in increased expression of BCAT1 mRNA CTD PMID:25710175 perfluorooctane-1-sulfonic acid increases expression ISO RGD:735669 6480464 perfluorooctane sulfonic acid results in increased expression of BCAT1 protein CTD PMID:26178269 phenylbutazone increases expression EXP 6480464 Phenylbutazone results in increased expression of BCAT1 mRNA CTD PMID:23558518 potassium chromate increases expression ISO RGD:1345403 6480464 potassium chromate(VI) results in increased expression of BCAT1 mRNA CTD PMID:22714537 progesterone multiple interactions ISO RGD:1345403 6480464 [Estradiol co-treated with Progesterone] results in increased expression of BCAT1 mRNA CTD PMID:20660070 quercetin decreases expression ISO RGD:1345403 6480464 Quercetin results in decreased expression of BCAT1 mRNA CTD PMID:21632981 scopolamine increases expression EXP 6480464 Scopolamine results in increased expression of BCAT1 mRNA CTD PMID:17540011 silicon dioxide increases expression ISO RGD:1345403 6480464 Silicon Dioxide analog results in increased expression of BCAT1 mRNA CTD PMID:25895662 sodium arsenite decreases expression ISO RGD:1345403 6480464 sodium arsenite results in decreased expression of BCAT1 mRNA CTD PMID:34032870 Soman increases expression EXP 6480464 Soman results in increased expression of BCAT1 mRNA CTD PMID:19281266 sunitinib increases expression ISO RGD:1345403 6480464 Sunitinib results in increased expression of BCAT1 mRNA CTD PMID:31533062 T-2 toxin decreases expression ISO RGD:1345403 6480464 T-2 Toxin results in decreased expression of BCAT1 mRNA CTD PMID:34581912 tamibarotene affects expression ISO RGD:1345403 6480464 tamibarotene affects the expression of BCAT1 mRNA CTD PMID:15498508 tamoxifen affects expression ISO RGD:735669 6480464 Tamoxifen affects the expression of BCAT1 mRNA CTD PMID:17555576 temozolomide decreases expression ISO RGD:1345403 6480464 Temozolomide results in decreased expression of BCAT1 mRNA CTD PMID:31758290 testosterone multiple interactions EXP 6480464 [bisphenol A co-treated with Testosterone] results in increased expression of BCAT1 mRNA CTD PMID:26496021 tetrachloromethane increases expression ISO RGD:735669 6480464 Carbon Tetrachloride results in increased expression of BCAT1 mRNA CTD PMID:17484886 thapsigargin increases expression ISO RGD:1345403 6480464 Thapsigargin results in increased expression of BCAT1 mRNA CTD PMID:22378314 , PMID:29453283 titanium dioxide decreases expression ISO RGD:735669 6480464 titanium dioxide results in decreased expression of BCAT1 mRNA CTD PMID:29264374 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of BCAT1 mRNA CTD PMID:30012374 triamterene increases expression EXP 6480464 Triamterene results in increased expression of BCAT1 mRNA CTD PMID:23558518 tributylstannane multiple interactions EXP 6480464 [bisphenol A co-treated with tributyltin] results in decreased expression of BCAT1 mRNA CTD PMID:31129395 Tributyltin oxide increases expression ISO RGD:735669 6480464 bis(tri-n-butyltin)oxide results in increased expression of BCAT1 mRNA CTD PMID:25270620 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of BCAT1 mRNA CTD PMID:33387578 trimellitic anhydride increases expression ISO RGD:735669 6480464 trimellitic anhydride results in increased expression of BCAT1 mRNA CTD PMID:19042947 trovafloxacin decreases expression ISO RGD:735669 6480464 trovafloxacin results in decreased expression of BCAT1 mRNA CTD PMID:35537566 tunicamycin increases expression ISO RGD:1345403 6480464 Tunicamycin results in increased expression of BCAT1 mRNA CTD PMID:22378314 , PMID:29453283 urethane decreases expression ISO RGD:1345403 6480464 Urethane results in decreased expression of BCAT1 mRNA CTD PMID:28818685 valproic acid decreases expression ISO RGD:735669 6480464 Valproic Acid results in decreased expression of BCAT1 mRNA CTD PMID:21427059 valproic acid decreases expression ISO RGD:1345403 6480464 Valproic Acid results in decreased expression of BCAT1 mRNA CTD PMID:23179753 , PMID:27188386 vincristine increases expression ISO RGD:1345403 6480464 Vincristine results in increased expression of BCAT1 mRNA CTD PMID:23649840
